Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Division of Diagnostic Radiology/Nuclear Medicine, Mayo Clinic, Rochester, Minnesota.
JACC Heart Fail. 2014 Jun;2(3):298-305. doi: 10.1016/j.jchf.2014.02.007. Epub 2014 Apr 30.
This study sought to quantitate total blood volume (TBV) in patients hospitalized for decompensated chronic heart failure (DCHF) and to determine the extent of volume overload, and the magnitude and distribution of blood volume and body water changes following diuretic therapy.
The accurate assessment and management of volume overload in patients with DCHF remains problematic.
TBV was measured by a radiolabeled-albumin dilution technique with intravascular volume, pre-to-post-diuretic therapy, evaluated at hospital admission and at discharge. Change in body weight in relation to quantitated TBV was used to determine interstitial volume contribution to total fluid loss.
Twenty-six patients were prospectively evaluated. Two patients had normal TBV at admission. Twenty-four patients were hypervolemic with TBV (7.4 ± 1.6 liters) increased by +39 ± 22% (range, +9.5% to +107%) above the expected normal volume. With diuresis, TBV decreased marginally (+30 ± 16%). Body weight declined by 6.9 ± 5.2 kg, and fluid intake/fluid output was a net negative 8.4 ± 5.2 liters. Interstitial compartment fluid loss was calculated at 6.2 ± 4.0 liters, accounting for 85 ± 15% of the total fluid reduction.
TBV analysis demonstrated a wide range in the extent of intravascular overload. Dismissal measurements revealed marginally reduced intravascular volume post-diuretic therapy despite large reductions in body weight. Mobilization of interstitial fluid to the intravascular compartment with diuresis accounted for this disparity. Intravascular volume, however, remained increased at dismissal. The extent, composition, and distribution of volume overload are highly variable in DCHF, and this variability needs to be taken into account in the approach to individualized therapy. TBV quantitation, particularly serial measurements, can facilitate informed volume management with respect to a goal of treating to euvolemia.
本研究旨在量化因失代偿性慢性心力衰竭(DCHF)住院患者的总血容量(TBV),并确定容量超负荷的程度,以及利尿剂治疗后血容量和身体水分的变化幅度和分布。
准确评估和管理 DCHF 患者的容量超负荷仍然存在问题。
使用放射性标记白蛋白稀释技术,在入院时和出院时测量血管内容量,评估利尿剂治疗前后的 TBV。根据定量 TBV 与体重变化的关系,确定间质体积对总液体丢失的贡献。
26 例患者前瞻性评估。入院时 2 例患者 TBV 正常。24 例患者呈血容量过多,TBV(7.4±1.6 升)比预期正常容量增加+39±22%(范围,+9.5%至+107%)。利尿后,TBV 略有下降(+30±16%)。体重下降 6.9±5.2kg,液体摄入/液体输出为净负 8.4±5.2 升。间质腔液体丢失量为 6.2±4.0 升,占总液体减少量的 85±15%。
TBV 分析显示,血管内超负荷的程度差异很大。尽管体重明显减轻,但利尿剂治疗后测量的血管内容积仍略有减少。利尿后间质液向血管腔的转移解释了这种差异。然而,在出院时,血管内容量仍处于增加状态。DCHF 中的容量超负荷的程度、组成和分布具有高度的可变性,在个体化治疗方法中需要考虑这种可变性。TBV 定量,特别是连续测量,可以有助于在治疗目标为容量正常化的情况下,进行明智的容量管理。